Informed consent was obtained from 14 patients with COPD who were referred to this study by their physician and from six healthy nonsmoking volunteers obtained from laboratory personel. All patients with COPD had been heavy smokers but all had stopped a minimum of five years earlier; none of the healthy group was a smoker. Each subject underwent a complete physical examination, including a 12-lead ECG, complete pulmonary function test, and arterialized capillary blood gas determinations and pH analysis. The patients with COPD were randomly divided into a control and a treatment group. All subjects were to perform weekly maximum expiratory flow volume (MEFV) curves, pulmonary diffusing capac­ity (Deo), and graded exercise protocol with oximetry (SoxiOJ over a 21-week period. The data collected during the first three weeks would serve to establish baseline values. Then subjects in the treatment group and healthy group would take 400 mg of pentoxi­fylline three times daily for the ensuing 12 weeks. Each patient would be followed up for the six weeks after treatment with the medication was stopped.

Read the rest of this entry »

Pentoxifylline is a trisubstituted xanthine derivative designated chemically as l-(5-oxohexyl)-3, 7-di- methylxanthine with rheologic and vasomotor effects. It has been shown to decrease blood viscosity by increasing erythrocyte deformability, reducing plate­let aggregation, and promoting thrombolysis. It also causes vasodilation. The drug is currently used in patients with peripheral vascular disease to increase blood perfusion and improve oxygen delivery. In addition, pentoxifylline has been reported to increase the cardiac index and there is preliminary evidence that it can reduce hypoxia-induced pulmonary vaso­constriction.

Read the rest of this entry »

The studies that have been performed on respira­tory muscle endurance are based on the capacity of the respiratory muscles to sustain and generate high levels of pressure. The most common test consists of generating a pressure against a given resistive inspi­ratory load. In our study, we used the Nickerson, Keens and Kelsen methods, that consist of breath­ing through a constant threshold load equivalent to 65 percent of the MIP. This pressure lies within the range of critical pressure required to induce respiratory muscle fatigue in normal subjects. The Ti/Tтот ratio was kept constant at 0.5, as variations in this ratio during the test change the time of endurance under the inspiratory load owing to the fact that the endurance capacity of the inspiratory muscles depends on the ventilatory pattern and on muscular force generated. It is a proven fact that the application of submaximum inspiratory loads produces low-fre­quency fatigue in normal subjects. The MIP is a measure of the maximum force generated by all the respiratory muscles and, in turn, it measures the muscular response to the high-frequency voluntary activation of the respiratory muscles. In healthy individuals, the MIP decreases significantly five min­utes after breathing has begun through the test with inspiratory load and this reduction reflects the re­duction in the mechanical capacity of the respiratory muscles to generate pressure.

We have shown that in patients with COPD the MIP is decreased at the end of the test with respect to its basal value, but not significantly (85.7 to 82.6 cm H20). The decrease in MIP becomes significant (79.1 cm H20) ten minutes after exhaustion (Table 2) with respect to its basal value.

Read the rest of this entry »

It can be seen in Table 1 that there is evidence that the patients suffered a moderate obstruction of air flow and the volumes are increased. Three of the patients had a Deo of less than 80 percent due to clinical and radiologic signs of pulmonary emphy­sema. The average TLIM of the sample was 3.7 ±1.96 minutes. The anthropometric measure­ments were normal.

Read the rest of this entry »

Sample

The study was conducted on eight male patients with COPD in stable phase, that is, the patients had not shown any symptoms of acute relapse in a period of at least two months prior to the study. The average age was 60.57 ±7.59 years, the height was 162.14 ±10.43 cm, and the weight was 65±9.7 kg. The patients did not have any other type of cardiorespiratory, endocrine, neuro­muscular, or hepatic illness. We explained the protocol to be followed and all patients gave their consent. Various tests were conducted simultaneously within the first week of inclusion in the study.

Read the rest of this entry »

To or some years now, resistive inhalational loads have been used to evaluate the endurance capacity of the inspiratory musculature under exertion. The capacity to sustain the muscular exertion required to inhale depends on the force and duration of the inhalational muscle contraction, which is determined by the pressure-time ratio. It is known that healthy subjects and patients with COPD become fatigued with diaphragmatic pressure-time ratios over 0.15. This technique is also used as a rehabilitative measure for the respiratory muscle function, as well as in the evaluation of the effectiveness of certain drugs such as caffeine. In patients with COPD, it is observed that the maximum inspiratory pressures (MIPs) and the exertion capacity are diminished owing probably to pulmonary hyperinflation, to changes in the ex­change of gases, and to concomitant nutritional defi­ciencies.

Nevertheless, the effects of application of resistive inhalational loads on the maximum inspiratory and expiratory pressures in such patients are not known.

Read the rest of this entry »

Fibrinolysis occurred within 1.5 hours after receiv­ing rt-PA, based upon the prompt elevation of frag­ment D-dimers. The assay that was used was specific for fibrin and did not detect fibrinogen degradation products. The observed reduction of fibrinogen levels in each of three patients receiving 80 mg of rt-PA was consistent, in addition, with a systemic lysis of fibrin­ogen. In spite of the prompt onset of fibrinolysis, there was only a limited change of the pulmonary vascular resistance and no significant improvement of the angiograms at 2 hours. The perfusion scans, however, showed trends toward more rapid improvement by 24 hours than patients treated with placebo.

Reported experience using rt-PA for venous throm- boemboli in patients is limited, and there are no placebo controlled studies. Bounameaux and associates reported the first treatment of a patient with pulmonary embolism using rt-PA. The patient treated with rt-PA plus heparin showed almost com­plete recanalization of the branches of the left pul­monary artery and recanalization of the vessels to the right lower lobe in 24 hours.

Read the rest of this entry »

Pages: Prev 1 2 3 4 5 6 7 8 9 10 ...71 72 73 Next
top